Scholarly Index
Robert Croop
Biohaven Pharmaceuticals (United States); 2,928 total citations; 130 total publications; best world rank #54
Biohaven Pharmaceuticals (United States)
2,928Total citations
130Total publications
23H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Migraine and Headache Studies | Lifetime | 559 | US 179 | 94.34 |
| Trigeminal Neuralgia and Treatments | Lifetime | 612 | US 203 | 91.06 |
| Sympathectomy and Hyperhidrosis Treatments | Lifetime | 976 | US 361 | 79.14 |
| Migraine and Headache Studies | 2021-2025 | 54 | US 10 | 97.90 |
| Cardiovascular Syncope and Autonomic Disorders | 2021-2025 | 92 | US 33 | 93.22 |
| Trigeminal Neuralgia and Treatments | 2021-2025 | 81 | US 13 | 93.67 |
| Olfactory and Sensory Function Studies | 2021-2025 | 277 | US 58 | 89.32 |
| Psychosomatic Disorders and Their Treatments | 2021-2025 | 312 | US 62 | 88.81 |
| Neuroprotection in Stroke and Neurodegeneration | 2021-2025 | 207 | US 28 | 85.45 |
| Sympathectomy and Hyperhidrosis Treatments | 2021-2025 | 71 | US 17 | 86.56 |
| Pharmacological Effects and Toxicity Studies | 2021-2025 | 545 | US 147 | 84.68 |